BioSolution Designs Revenue and Competitors
Estimated Revenue & Valuation
- BioSolution Designs's estimated annual revenue is currently $697.5k per year.
- BioSolution Designs's estimated revenue per employee is $77,500
Employee Data
- BioSolution Designs has 9 Employees.
- BioSolution Designs grew their employee count by -18% last year.
BioSolution Designs's People
| Name | Title | Email/Phone |
|---|
BioSolution Designs Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.3M | 2 | 0% | N/A | N/A |
#2 | $3.6M | 46 | -31% | $17.5M | N/A |
#3 | $3.6M | 46 | -34% | $10.5M | N/A |
#4 | $30.2M | 156 | 0% | $69.4M | N/A |
#5 | $11.8M | 76 | -15% | N/A | N/A |
#6 | $1.7M | 11 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $8.8M | 57 | 19% | N/A | N/A |
#9 | $0.2M | 1 | -86% | N/A | N/A |
#10 | $2M | 13 | 18% | N/A | N/A |
What Is BioSolution Designs?
BSD is a biotechnology design firm focused on developing high-value products for Life Science Researchers and Biotherapeutics Product Developers.
keywords:N/A
N/A
Total Funding
9
Number of Employees
$697.5k
Revenue (est)
-18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BioSolution Designs News
2022-04-20 - U.S. Food and Drug Administration Approves Camzyos for the Treatment of
Adults With Symptomatic New York Heart Association Class II-III Obstructive
Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms
... at Emergent BioSolutions (NYSE: EBS), during which she successfully introduced a drug to patients from design stage into clinic.
2022-04-17 - Global Anthrax Vaccines Market 2022 Segment Overview with ...
... openings, constraints, drivers, and by and large Anthrax Vaccines designs. ... Emergent BioSolutions; Merial; Merck; Zoetis; Bayer Sanidad Animal...
Other Companies in Frederick
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.3M | 9 | 50% | N/A |
#2 | $0.7M | 9 | -10% | N/A |
#3 | $0.7M | 9 | 13% | N/A |
#4 | $0.9M | 10 | 0% | N/A |
#5 | $1.6M | 10 | 0% | N/A |